Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation.

Nutrients · 2019 · PMC6683087 · PMID 31252674

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

For example, Malawian children, aged 5 to 168 months, suffering from SAM who received ready-to-use-therapeutic-food (RUTF) with a synbiotic for approximately 33 days (median) in a double-blind efficacy randomized controlled trial showed a trend towards reduced outpatient mortality when compared to those who received RUTF alone ( P = 0.06) [ 218 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.